Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease

Circulation Research
Marco CattaruzzaMarkus Hecker

Abstract

Coronary heart disease (CHD) is based on the development of atherosclerosis in coronary arteries. Shear stress-induced endothelial nitric oxide (NO) release not only contributes to local blood pressure control but also effectively helps to retard atherosclerosis. Therefore, functionally relevant polymorphisms in the endothelial NO synthase (NOS-3) gene may contribute to the development of CHD. NOS-3 expression was analyzed in endothelial cells isolated from umbilical cords genotyped for the -786C/T single nucleotide polymorphism (SNP) of the human nos-3 gene. Moreover, NO-dependent relaxation was examined in segments of saphenous vein isolated from genotyped patients undergoing aortocoronary bypass surgery, and patients subjected to quantitative coronary angiography were genotyped to verify an association between this SNP and CHD. Shear stress-induced NOS-3 mRNA and protein expression was present in TT and CT genotype cells but absent in cells with CC genotype. Pretreatment of these cells with a decoy oligonucleotide comprising position -800 to -779 of the C-type nos-3 promoter reconstituted shear stress-induced NOS-3 expression. These results were confirmed by reporter gene analysis with the corresponding nos-3 promoter lucife...Continue Reading

References

Jan 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L J Ignarro
Oct 23, 1986·The New England Journal of Medicine·P L LudmerP Ganz
Dec 11, 1999·Nucleic Acids Research·E WingenderF Schacherer
Jun 24, 2000·Annals of the New York Academy of Sciences·M A GimbroneG Garcia-Cardeña
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Swen WagnerMichael Loos
Feb 26, 2003·Clinical Chemistry·Maria Giovanna ColomboAldo Clerico
Jul 10, 1908·Science·G H Hardy

❮ Previous
Next ❯

Citations

May 26, 2007·Zeitschrift für Rheumatologie·I Melchers, M Cattaruzza
Apr 28, 2006·Current Atherosclerosis Reports·Nageswara R MadamanchiMarschall Runge
Sep 9, 2011·Journal of Toxicology and Environmental Health. Part a·Kátia Cristina de MarcoFernando Barbosa
Sep 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·John P A Ioannidis, Fotini K Kavvoura
Feb 17, 2006·Current Opinion in Nephrology and Hypertension·Martin W McBrideAnna F Dominiczak
Dec 13, 2012·Science Signaling·Sahana Suresh BabuMarco Cattaruzza
Apr 15, 2009·Infection and Immunity·Gunanidhi DhangadamajhiManoranjan Ranjit
Sep 16, 2005·Heart·L C Jones, A D Hingorani
Jul 24, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Joon-Young ParkMichael D Brown
Oct 29, 2013·Journal of Cardiothoracic Surgery·José HinzAron Frederik Popov
Apr 6, 2006·Clinical Medicine & Research·Zhihong Yang, Xiu-Fen Ming
Jul 16, 2014·Expert Review of Proteomics·Sabika FirasatAbdul R Asif
Feb 13, 2016·Genetic Testing and Molecular Biomarkers·Cigdem Yuce KahramanAbdulgani Tatar
Jul 14, 2010·Cardiology Clinics·Dan Farbstein, Andrew P Levy
Feb 23, 2010·Peptides·Agnaldo Bruno ChiesElias Fernando Daniel
Feb 2, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mohd Suhail AkhterRenu Saxena
Jun 13, 2009·Vascular Pharmacology·Agnaldo Bruno Chies, Patrícia de Souza Rossignoli
Apr 6, 2006·Journal of Internal Medicine·D G HarrisonC Searles
May 11, 2010·International Journal for Numerical Methods in Engineering·Daniel R EinsteinMark B Ratcliffe
Dec 29, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Valeria C Sandrim
Jul 20, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Domingos L S RiosMara H Hutz
Jun 1, 2005·Neuroscience Letters·Eliana VenturelliElio Scarpini
Jul 5, 2015·Vascular Pharmacology·Patrícia de Souza RossignoliAgnaldo Bruno Chies
Sep 19, 2006·Journal of the American College of Cardiology·Gian Paolo RossiAchille C Pessina
Jan 21, 2014·Journal of Molecular and Cellular Cardiology·Elizabeth MurphyCharles Steenbergen
Jun 25, 2016·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Rachel D SimmonsHanjoong Jo
Oct 17, 2014·Journal of Psychopharmacology·Sarah Kittel-SchneiderAndreas Reif
Jun 15, 2007·Human Molecular Genetics·Elizabeth T Cirulli, David B Goldstein
May 4, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Carlos H G SpontonAngelina Zanesco
Oct 16, 2004·Circulation Research·Thomas F Lüscher, Roberto Corti
Aug 22, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Abdul R AsifMarco Cattaruzza
Nov 30, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kristopher S Cunningham, Avrum I Gotlieb
Oct 20, 2005·Current Opinion in Cardiology·Ulf Landmesser, Helmut Drexler
Oct 5, 2006·American Journal of Epidemiology·Juan P CasasAroon D Hingorani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.